Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Yang J, Yang J, Hu YJ. Characteristics of clinical trials of new oncology drugs approved in China. Cancer 2024;130:671-682. [PMID: 37985356 DOI: 10.1002/cncr.35106] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 09/21/2023] [Accepted: 10/16/2023] [Indexed: 11/22/2023]

For:	Yang J, Yang J, Hu YJ. Characteristics of clinical trials of new oncology drugs approved in China. Cancer 2024;130:671-682. [PMID: 37985356 DOI: 10.1002/cncr.35106] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2023] [Revised: 09/21/2023] [Accepted: 10/16/2023] [Indexed: 11/22/2023]

Number

Cited by Other Article(s)

Nikanjam M, Kurzrock R. Critical insights into the evolving drug-approval process in China. Cancer 2024;130:665-667. [PMID: 38165313 PMCID: PMC10922387 DOI: 10.1002/cncr.35186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2024]